212 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

ORIG3N Competitors or Alternatives

ORIG3N's top competitors include Ultragenyx, Qrativ and Sarepta.

Unlock 21 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

ORIG3N's company profile

Robin Y. Smith

Co-Founder & CEO

80/100
25 - 100
$36M
$100K - 5M
  • $36M
    $100K - 5M
  • 25 - 100
    $36M
  • $100K - 5M
  • 80/100
  • 25 - 100
  • $36M
  • $100K - 5M
View ProfileView
1
ORIG3N's Competitor - Ultragenyx logo

Emil D. Kakkis

President & CEO

83/100
1,310
$600.8M
$560.2M
  • $600.8M
    $560.2M
  • 1,310
    $600.8M
  • $560.2M
  • 83/100
  • 1,310
  • $600.8M
  • $560.2M
View ProfileView
2
ORIG3N's Competitor - Qrativ logo

Murali Aravamudan

Founder & CEO

79/100
25 - 100
$8.3M
$100K - 5M
  • $8.3M
    $100K - 5M
  • 25 - 100
    $8.3M
  • $100K - 5M
  • 79/100
  • 25 - 100
  • $8.3M
  • $100K - 5M
View ProfileView
3
ORIG3N's Competitor - Sarepta logo

Douglas S. Ingram

President & CEO

89/100
840
$2.5B
$1.9B
  • $2.5B
    $1.9B
  • 840
    $2.5B
  • $1.9B
  • 89/100
  • 840
  • $2.5B
  • $1.9B
View ProfileView
4
ORIG3N's Competitor - twoXAR logo

Andrew A. Radin

Co-Founder & CEO

81/100
25 - 100
$14.5M
$5M - 25M
  • $14.5M
    $5M - 25M
  • 25 - 100
    $14.5M
  • $5M - 25M
  • 81/100
  • 25 - 100
  • $14.5M
  • $5M - 25M
View ProfileView
5
ORIG3N's Competitor - Santhera logo

Dario Eklund

CEO

100/100
56
$372.6M
$122.9M
  • $372.6M
    $122.9M
  • 56
    $372.6M
  • $122.9M
  • 100/100
  • 56
  • $372.6M
  • $122.9M
View ProfileView
ORIG3N's top 24 competitors are Ultragenyx, Qrativ, Sarepta, BioMarin, twoXAR, Santhera, Abeona, BERG, Clementia Pharmaceuticals, Inc., Adaptimmune, Atomwise, Aegerion Pharmaceuticals, AstraZeneca, Kite Pharma, Bristol-Myers Squibb, Merck, Celgene, Strongbridge Biopharma, Drais Pharmaceuticals, Inc., Receptos, NewLink Genetics, PTC, Argos Therapeutics and Esperion. Together they have raised over 40.2B between their estimated 212.5K employees. ORIG3N's revenue is the ranked 21th among it's top 10 competitors. The top 10 competitors average 7.4B. ORIG3N has 61 employees and is ranked 18th among it's top 10 competitors. The top 10 competitors average 8,500.

ORIG3N VS Ultragenyx

Ultragenyx is seen as one of ORIG3N's top competitors. Ultragenyx's headquarters is in Novato, California, and was founded in 2010. Like ORIG3N, Ultragenyx also works within the Biotechnology industry. Ultragenyx generates 16,006% of ORIG3N's revenue.

ORIG3N VS Qrativ

Qrativ is one of ORIG3N's top rivals. Qrativ was founded in 2017, and its headquarters is in Cambridge, Massachusetts. Like ORIG3N, Qrativ also works within the Biotechnology field. Qrativ has 36 fewer employees than ORIG3N.

ORIG3N VS Sarepta

Sarepta is ORIG3N's #3 rival. Sarepta is a Public company that was founded in 1980 in Cambridge, Massachusetts. Like ORIG3N, Sarepta also competes in the Biotechnology sector. Compared to ORIG3N, Sarepta has 779 more employees.

Looking for similar companies to ORIG3N?

Similar Companies

Biotechnology companies in Boston

See 270 companies 
Biotechnology companies in Greater Boston

See 1,266 companies 
Pharmaceuticals & Biotechnology companies in Boston

See 340 companies 
Biotechnology companies in Massachusetts

See 1,343 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,622 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,717 companies 
Companies in Boston with revenue in $100K-5.0M range

See 3,373 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 
Biotechnology companies with employees in 25-100 range

See 5,165 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for ORIG3N and ORIG3N's Competitors

April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE:MRK) of a c...
March 31, 2025Sustainabilityhq
NEW YORK, March 31, 2025 /PRNewswire/ - Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "C...
April 1, 2025Medthority
Positive CHMP opinion for Opdivo subcutaneous formulation across multiple solid tumor indications....
April 2, 2025Pharmabiz
Positive results from the PURSUIT phase IIb trial for AstraZeneca's AZD0780 demonstrated a statistically significant low─density lipoprotein cholestero...
April 2, 2025Seekingalpha
Shutter2U/iStock via Getty Images BioMarin Pharmaceutical ( NASDAQ: BMRN ) said on Wednesday that its late-stage trial of PALYNZIQ, a treatment for phe...
April 1, 2025Benzinga
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") MRK of a class ac...
March 31, 2025FinanzNachrichten
NEW YORK CITY (dpa-AFX) - Halozyme Therapeutics, Inc. (HALO), Monday announced that Bristol Myers Squibb (BMY) received a positive opinion from the Com...
April 1, 2025Medthority
CHMP recommends Calquence plus chemoimmunotherapy for approval as the first BTK inhibitor for mantle cell lymphoma....
April 2, 2025Rttnews
BioMarin Pharmaceutical Inc. ( BMRN ) Wednesday said its Phase 3 PEGASUS study evaluating Palynziq in adolescents aged 12-17 with phenylketonuria (PKU)...
April 1, 2025Nasdaq
(RTTNews) - Abbisko Therapeutics Co., Ltd. announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an op...

Frequently Asked Questions about ORIG3N

  1. Who are ORIG3N's top competitors?

    ORIG3N's top 3 competitors are Ultragenyx, Qrativ, Sarepta.

  2. Who is similar to ORIG3N?

    Ultragenyx is the most similar to ORIG3N. Qrativ and Sarepta are also similar to ORIG3N.

  1. Are ORIG3N and Ultragenyx competitors?

    Yes, Ultragenyx is one of ORIG3N’s top competitors.